Related Experiment Videos
SIRT1 negatively regulates amyloid-beta-induced inflammation via the NF-κB pathway
1Tenth People's Hospital, School of Medicine, Affiliate of Tongji University, Department of Ophthalmology, Shanghai, China.
Abstract:
Chronic inflammation induced by amyloid-beta (Aβ) plays a key role in the development of age-related macular degeneration (AMD), and matrix metalloproteinase-9 (MMP-9), interleukin (IL)-6, and IL-8 may be associated with chronic inflammation in AMD. Sirtuin 1 (SIRT1) regulates inflammation via inhibition of nuclear factor-kappa B (NF-κB) signaling, and resveratrol has been reported to prevent Aβ-induced retinal degeneration; therefore, we investigated whether this action was mediated via activation of SIRT1 signaling. Human adult retinal pigment epithelial (RPE) cells were exposed to Aβ, and overactivation and knockdown of SIRT1 were performed to investigate whether SIRT1 is required for abrogating Aβ-induced inflammation. We found that Aβ-induced RPE barrier disruption and expression of IL-6, IL-8, and MMP-9 were abrogated by the SIRT1 activator SRT1720, whereas alterations induced by Aβ in SIRT1-silenced RPE cells were not attenuated by SRT1720. In addition, SRT1720 inhibited Aβ-mediated NF-κB activation and decrease of the NF-κB inhibitor, IκBα. Our findings suggest a protective role for SIRT1 signaling in Aβ-dependent retinal degeneration and inflammation in AMD.
Insights
Sirtuin 1 (SIRT1) activation protects against amyloid-beta (Aβ) induced inflammation and retinal degeneration in age-related macular degeneration (AMD). SRT1720, a SIRT1 activator, inhibited Aβ-mediated inflammation and barrier disruption in retinal pigment epithelial cells.
Area of Science:
- Ophthalmology
- Cell Biology
- Molecular Biology
Background:
- Chronic inflammation driven by amyloid-beta (Aβ) is implicated in age-related macular degeneration (AMD).
- Matrix metalloproteinase-9 (MMP-9), interleukin-6 (IL-6), and interleukin-8 (IL-8) are potential mediators of inflammation in AMD.
- Sirtuin 1 (SIRT1) regulates inflammation by inhibiting nuclear factor-kappa B (NF-κB) signaling.
Purpose of the Study:
- To investigate if SIRT1 signaling activation mediates the protective effects of resveratrol against Aβ-induced retinal degeneration.
- To determine the role of SIRT1 in abrogating Aβ-induced inflammation in human adult retinal pigment epithelial (RPE) cells.
Main Methods:
- Human adult RPE cells were exposed to Aβ.
- SIRT1 activity was modulated through overactivation and knockdown.
- The effect of SIRT1 activator SRT1720 on Aβ-induced cellular changes was assessed.
- NF-κB activation and IκBα levels were analyzed.
Main Results:
- SRT1720 abrogated Aβ-induced RPE barrier disruption and expression of IL-6, IL-8, and MMP-9.
- These protective effects were not observed in SIRT1-silenced RPE cells.
- SRT1720 inhibited Aβ-mediated NF-κB activation and prevented the decrease of IκBα.
Conclusions:
- SIRT1 signaling plays a protective role in mitigating Aβ-dependent retinal degeneration and inflammation associated with AMD.
- Targeting SIRT1 may offer a therapeutic strategy for managing AMD.
- The findings highlight the importance of the SIRT1/NF-κB pathway in RPE cell response to Aβ.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of the Unfolded Protein Response
TGF - β Signaling Pathway
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Nuclear Protein Sorting
The JAK-STAT Signaling Pathway